-
1 Comment
Poly Medicure Limited is currently in a long term uptrend where the price is trading 36.9% above its 200 day moving average.
From a valuation standpoint, the stock is 113.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 10.2.
Poly Medicure Limited's total revenue rose by 12.8% to $2B since the same quarter in the previous year.
Its net income has increased by 41.1% to $353M since the same quarter in the previous year.
Finally, its free cash flow grew by 39.0% to $849M since the same quarter in the previous year.
Based on the above factors, Poly Medicure Limited gets an overall score of 4/5.
| Exchange | NSE |
|---|---|
| CurrencyCode | INR |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| ISIN | INE205C01021 |
| Market Cap | 195B |
|---|---|
| PE Ratio | 54.13 |
| Target Price | 2277 |
| Dividend Yield | 0.0% |
| Beta | 0.01 |
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, such as blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, foley balloon and urine drainage catheters, and urine collection bags with measured volume meters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for POLYMED.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
